Algeria's Minister of Health, Professor Mohamed Seddik Ait Masoudan, and Derek O'Leary, Regional General Manager for IMETA (India, Middle East, Turkey, and Africa), signed a cooperation agreement between the Health Ministry and Boehringer Ingelheim on Thursday. The agreement aims to support the Ministry's efforts in stroke care and rare diseases. The signing ceremony took place at the Ministry's headquarters.
The agreement was signed on behalf of the Health Ministry by Souheila, Director of Treatment Programs and Medical Ethics, and on behalf of Boehringer Ingelheim Algeria by Samir Hamak, Country Manager. This partnership is part of a broader effort to strengthen cooperation and collaboration in public health. The agreement is based on scientific evidence and data, allowing for the evaluation of available resources and capacities.
The partnership aims to identify priority needs and develop suitable mechanisms to improve patient care. The agreement also includes support and enhancement of healthcare professionals' capacities, as well as accompaniment of efforts to digitize the stroke care system. This will contribute to improving care pathways, enhancing coordination among various stakeholders, and upgrading the quality of services provided to patients.
According to the Health Ministry, this collaboration is part of its efforts to develop care pathways for priority diseases, enhance the quality of healthcare services, and promote prevention, early diagnosis, and comprehensive care. The Ministry seeks to respond to patients' needs and support the improvement of the national healthcare system's performance.
The agreement is a significant step towards achieving these goals, as it brings together the expertise of Boehringer Ingelheim and the Health Ministry. The partnership is expected to have a positive impact on the lives of patients with stroke and rare diseases in Algeria.
The Health Ministry's efforts to develop partnerships with international companies like Boehringer Ingelheim demonstrate its commitment to improving the healthcare system. The Ministry is working to strengthen its collaborations with various stakeholders to enhance the quality of healthcare services.
The partnership between the Health Ministry and Boehringer Ingelheim is a positive development in Algeria's healthcare sector. The agreement is expected to improve the care and support provided to patients with stroke and rare diseases, and to contribute to the overall development of the healthcare system.
Key points
- The Algerian Health Ministry has partnered with Boehringer Ingelheim to support stroke patients and those with rare diseases.
- The partnership aims to enhance stroke care and support patients with rare diseases.
- The agreement includes support for healthcare professionals and the digitization of the stroke care system.
